[Mental effects of Wallerox therapy in the aged].
D000368:Aged; D000375:Aging; D002018:Bufanolides / Q000627:therapeutic use; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D006801:Humans; D007361:Intelligence Tests; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D013806:Theophylline / Q000627:therapeutic use*
D002018:Bufanolides; D009539:Nicotinic Acids; D010919:Placebos; D004877:Ergoloid Mesylates; D013806:Theophylline
Psychische Auswirkungen nach Wallerox-Behandlung im höheren Alter.